Literature DB >> 8449936

Functional characterization of flavin-containing monooxygenase 1B1 expressed in Saccharomyces cerevisiae and Escherichia coli and analysis of proposed FAD- and membrane-binding domains.

M P Lawton1, R M Philpot.   

Abstract

A cDNA encoding the flavin-containing monooxygenase of rabbit lung (FMO 1B1) was expressed in yeast and Escherichia coli and the recombinant enzymes characterized. A high copy, isopropyl-1-thio-beta-D-galactopyranoside (IPTG)-inducible E. coli expression vector, pKKHC, was used for expression in E. coli strain JM109, and a galactose-inducible vector, YEp53, was used for expression in yeast strain 334. Following transcriptional induction with IPTG or galactose, subcellular fractions were prepared and analyzed immunochemically and catalytically. Antibodies to rabbit FMO 1B1 were used to detect the recombinant proteins in the 100,000 x g pellet prepared from the 10,000 x g supernatant fraction of yeast homogenates and the 2,000 x g supernatant fraction of E. coli homogenates. No FMO 1B1 was detected in cytosol. Mobilities of the recombinant proteins in SDS-polyacrylamide gel electrophoresis appeared identical to that of the native microsomal enzyme. Catalytic similarity to the native FMO 1B1 was demonstrated by the ability of the expressed enzymes to metabolize methimazole, thiourea, dimethylaniline, and cysteamine, but not chlorpromazine or imipramine. In addition, the recombinant enzymes exhibited a number of the unique physical properties associated with FMO 1B1, including stability to elevated temperature and activation by sodium cholate and magnesium chloride. Based on the specific content of FAD, the level of expression was estimated to be approximately 2% of the total protein in the E. coli 100,000 x g particulate fraction and 1% in the fraction from yeast. To demonstrate the utility of the E. coli expression system for studying structure/function relationships of the flavin-containing monooxygenase, two mutant FMOs were expressed and characterized. One mutant, formed by deletion of a putative membrane-anchoring peptide (the 26 carboxyl-terminal amino acids) was tested for membrane association. No difference in the subcellular distribution was found between the truncated and unmodified proteins, suggesting that the 26-residue COOH-terminal peptide is not important in membrane association. Catalytic analysis of the truncated FMO 1B1 established its functional similarity to the full-length protein, indicating that the COOH terminus does not contribute to any of the unique properties of the lung enzyme.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449936

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Ancestral-sequence reconstruction unveils the structural basis of function in mammalian FMOs.

Authors:  Callum R Nicoll; Gautier Bailleul; Filippo Fiorentini; María Laura Mascotti; Marco W Fraaije; Andrea Mattevi
Journal:  Nat Struct Mol Biol       Date:  2019-12-23       Impact factor: 15.369

2.  MICAL-1 is a negative regulator of MST-NDR kinase signaling and apoptosis.

Authors:  Yeping Zhou; Youri Adolfs; W W M Pim Pijnappel; Stephen J Fuller; Roel C Van der Schors; Ka Wan Li; Peter H Sugden; August B Smit; Alexander Hergovich; R Jeroen Pasterkamp
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

Review 3.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.

Authors:  Sharon K Krueger; David E Williams
Journal:  Pharmacol Ther       Date:  2005-06       Impact factor: 12.310

4.  The flavin monooxygenase Bs3 triggers cell death in plants, impairs growth in yeast and produces H2O2 in vitro.

Authors:  Christina Krönauer; Thomas Lahaye
Journal:  PLoS One       Date:  2021-08-19       Impact factor: 3.240

5.  Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesis.

Authors:  Martina Geier; Thorsten Bachler; Steven P Hanlon; Fabian K Eggimann; Matthias Kittelmann; Hansjörg Weber; Stephan Lütz; Beat Wirz; Margit Winkler
Journal:  Microb Cell Fact       Date:  2015-06-12       Impact factor: 5.328

6.  C. elegans flavin-containing monooxygenase-4 is essential for osmoregulation in hypotonic stress.

Authors:  Nisha Hirani; Marcel Westenberg; Paul T Seed; Mark I R Petalcorin; Colin T Dolphin
Journal:  Biol Open       Date:  2016-05-15       Impact factor: 2.422

7.  Production of drug metabolites by human FMO3 in Escherichia coli.

Authors:  Gianluca Catucci; Gianfranco Gilardi; Sheila J Sadeghi
Journal:  Microb Cell Fact       Date:  2020-03-20       Impact factor: 5.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.